236 related articles for article (PubMed ID: 22653322)
1. Short- and long-term effects of alkali therapy in chronic kidney disease: a systematic review.
Susantitaphong P; Sewaralthahab K; Balk EM; Jaber BL; Madias NE
Am J Nephrol; 2012; 35(6):540-7. PubMed ID: 22653322
[TBL] [Abstract][Full Text] [Related]
2. Low Serum Bicarbonate and CKD Progression in Children.
Brown DD; Roem J; Ng DK; Reidy KJ; Kumar J; Abramowitz MK; Mak RH; Furth SL; Schwartz GJ; Warady BA; Kaskel FJ; Melamed ML
Clin J Am Soc Nephrol; 2020 Jun; 15(6):755-765. PubMed ID: 32467307
[TBL] [Abstract][Full Text] [Related]
3. Effects of Sodium Bicarbonate in CKD Stages 3 and 4: A Randomized, Placebo-Controlled, Multicenter Clinical Trial.
Melamed ML; Horwitz EJ; Dobre MA; Abramowitz MK; Zhang L; Lo Y; Mitch WE; Hostetter TH
Am J Kidney Dis; 2020 Feb; 75(2):225-234. PubMed ID: 31699517
[TBL] [Abstract][Full Text] [Related]
4. Effects of Treatment of Metabolic Acidosis in CKD: A Systematic Review and Meta-Analysis.
Navaneethan SD; Shao J; Buysse J; Bushinsky DA
Clin J Am Soc Nephrol; 2019 Jul; 14(7):1011-1020. PubMed ID: 31196951
[TBL] [Abstract][Full Text] [Related]
5. Effects of oral alkali drug therapy on clinical outcomes in pre-dialysis chronic kidney disease patients: a systematic review and meta-analysis.
Shi H; Su X; Yan B; Li C; Wang L
Ren Fail; 2022 Dec; 44(1):106-115. PubMed ID: 35176947
[TBL] [Abstract][Full Text] [Related]
6. Impact of Serum Bicarbonate Levels on Muscle Mass and Kidney Function in Pre-Dialysis Chronic Kidney Disease Patients.
Kittiskulnam P; Srijaruneruang S; Chulakadabba A; Thokanit NS; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
Am J Nephrol; 2020; 51(1):24-34. PubMed ID: 31752000
[TBL] [Abstract][Full Text] [Related]
7. Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate.
Goraya N; Simoni J; Jo CH; Wesson DE
Kidney Int; 2014 Nov; 86(5):1031-8. PubMed ID: 24694986
[TBL] [Abstract][Full Text] [Related]
8. Does oral sodium bicarbonate therapy improve function and quality of life in older patients with chronic kidney disease and low-grade acidosis (the BiCARB trial)? Study protocol for a randomized controlled trial.
Witham MD; Band MM; Littleford RC; Avenell A; Soiza RL; McMurdo ME; Sumukadas D; Ogston SA; Lamb EJ; Hampson G; McNamee P;
Trials; 2015 Aug; 16():326. PubMed ID: 26231610
[TBL] [Abstract][Full Text] [Related]
9. Clinical and cost-effectiveness of oral sodium bicarbonate therapy for older patients with chronic kidney disease and low-grade acidosis (BiCARB): a pragmatic randomised, double-blind, placebo-controlled trial.
BiCARB study group
BMC Med; 2020 Apr; 18(1):91. PubMed ID: 32268897
[TBL] [Abstract][Full Text] [Related]
10. Metabolic acidosis is common and associates with disease progression in children with chronic kidney disease.
Harambat J; Kunzmann K; Azukaitis K; Bayazit AK; Canpolat N; Doyon A; Duzova A; Niemirska A; Sözeri B; Thurn-Valsassina D; Anarat A; Bessenay L; Candan C; Peco-Antic A; Yilmaz A; Tschumi S; Testa S; Jankauskiene A; Erdogan H; Rosales A; Alpay H; Lugani F; Arbeiter K; Mencarelli F; Kiyak A; Dönmez O; Drozdz D; Melk A; Querfeld U; Schaefer F;
Kidney Int; 2017 Dec; 92(6):1507-1514. PubMed ID: 28729033
[TBL] [Abstract][Full Text] [Related]
11. VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis.
Tangri N; Mathur VS; Bushinsky DA; Klaerner G; Li E; Parsell D; Stasiv Y; Walker M; Wesson DE; Wheeler DC; Perkovic V; Inker LA
J Am Soc Nephrol; 2024 Mar; 35(3):311-320. PubMed ID: 38261535
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of combined vs. single renin-angiotensin-aldosterone system blockade in chronic kidney disease: a meta-analysis.
Susantitaphong P; Sewaralthahab K; Balk EM; Eiam-ong S; Madias NE; Jaber BL
Am J Hypertens; 2013 Mar; 26(3):424-41. PubMed ID: 23382494
[TBL] [Abstract][Full Text] [Related]
13. Correction of metabolic acidosis improves muscle mass and renal function in chronic kidney disease stages 3 and 4: a randomized controlled trial.
Dubey AK; Sahoo J; Vairappan B; Haridasan S; Parameswaran S; Priyamvada PS
Nephrol Dial Transplant; 2020 Jan; 35(1):121-129. PubMed ID: 30053298
[TBL] [Abstract][Full Text] [Related]
14. Effects of veverimer on serum bicarbonate and physical function in women with chronic kidney disease and metabolic acidosis: a subgroup analysis from a randomised, controlled trial.
Mathur VS; Wesson DE; Tangri N; Li E; Bushinsky DA
BMC Nephrol; 2022 Feb; 23(1):82. PubMed ID: 35216581
[TBL] [Abstract][Full Text] [Related]
15. Association between serum Na-Cl level and renal function decline in chronic kidney disease: results from the chronic kidney disease Japan cohort (CKD-JAC) study.
Maruta Y; Hasegawa T; Yamakoshi E; Nishiwaki H; Koiwa F; Imai E; Hishida A
Clin Exp Nephrol; 2019 Feb; 23(2):215-222. PubMed ID: 30168046
[TBL] [Abstract][Full Text] [Related]
16. A prospective, multicenter, randomized, controlled study: the correction of metabolic acidosis with use of bicarbonate in Chronic Renal Insufficiency (UBI) Study.
Di Iorio B; Aucella F; Conte G; Cupisti A; Santoro D
J Nephrol; 2012; 25(3):437-40. PubMed ID: 21928233
[TBL] [Abstract][Full Text] [Related]
17. Fruit and Vegetable Treatment of Chronic Kidney Disease-Related Metabolic Acidosis Reduces Cardiovascular Risk Better than Sodium Bicarbonate.
Goraya N; Munoz-Maldonado Y; Simoni J; Wesson DE
Am J Nephrol; 2019; 49(6):438-448. PubMed ID: 30995657
[TBL] [Abstract][Full Text] [Related]
18. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
Alcázar Arroyo R
Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
[TBL] [Abstract][Full Text] [Related]
19. Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study.
Di Iorio BR; Bellasi A; Raphael KL; Santoro D; Aucella F; Garofano L; Ceccarelli M; Di Lullo L; Capolongo G; Di Iorio M; Guastaferro P; Capasso G;
J Nephrol; 2019 Dec; 32(6):989-1001. PubMed ID: 31598912
[TBL] [Abstract][Full Text] [Related]
20. Uric acid lowering therapies for preventing or delaying the progression of chronic kidney disease.
Sampson AL; Singer RF; Walters GD
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD009460. PubMed ID: 29084343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]